Petr Hubáček
- Epidemiology top 5%
- Infectious Diseases top 5%
- Oncology top 10%
- Immunology
- Hematology top 10%
- Co-authors
- Katherine N. WardHermann EinselePer LjungmanJoshua A. HillCatherine CordonnierRafael de la CámaraChristine RobinRoberto Crocchiolo
- Topics
- Cytomegalovirus and herpesvirus research (20 papers)Viral-associated cancers and disorders (13 papers)Antifungal resistance and susceptibility (10 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Petr Hubáček
54 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Epidemiology 700
- Infectious Diseases 380
- Oncology 328
- Immunology 143
- Hematology 135
Countries citing papers authored by Petr Hubáček
This map shows the geographic impact of Petr Hubáček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Hubáček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Hubáček more than expected).
Fields of papers citing papers by Petr Hubáček
This network shows the impact of papers produced by Petr Hubáček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Hubáček. The network helps show where Petr Hubáček may publish in the future.
Co-authorship network of co-authors of Petr Hubáček
This figure shows the co-authorship network connecting the top 25 collaborators of Petr Hubáček. A scholar is included among the top collaborators of Petr Hubáček based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Hubáček. Petr Hubáček is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 6 | |
| 5 | 87 | |
| 6 | 19 | |
| 7 | Reduction of Thymoglobuline from 7.5 mg/kg to 6 mg/kg in conditioning regimen extended time to the first cytomegalovirus detection after allogenic haematopoietic stem cell transplantation. | 1 |
| 8 | 77 | |
| 9 | 1 | |
| 10 | 33 | |
| 11 | 2 | |
| 12 | 7 | |
| 13 | 4 | |
| 14 | 1 | |
| 15 | 13 | |
| 16 | 1 | |
| 17 | 37 | |
| 18 | 33 | |
| 19 | 4 | |
| 20 | 22 |
About Petr Hubáček
Petr Hubáček is a scholar working on Transplantation, Infectious Diseases and Epidemiology, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (20 papers), Viral-associated cancers and disorders (13 papers) and Antifungal resistance and susceptibility (10 papers). The work is most often cited by research in Infectious Diseases (380 citations), Epidemiology (700 citations) and Hematology (135 citations). Petr Hubáček has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Katherine N. Ward, Hermann Einsele, Per Ljungman, Joshua A. Hill, Catherine Cordonnier, Rafael de la Cámara, Christine Robin, Roberto Crocchiolo, David Navarro and Tomáš Kalina. Their work appears in journals such as Journal of Clinical Microbiology, Frontiers in Immunology and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.